ARAP1-AS1:一种新的长非编码RNA,在人类癌症发展中起着至关重要的调节作用
Jialing Wang1, Hongliang Luo1, Lu Yang2
1Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330008, China.
Cancer cell international
|August 1, 2024
概括
长非编码RNA ARAP1-AS1在固体瘤中过度表达,导致癌症的进展. 本综述探讨了其作为生物标志物和治疗点的致癌作用和潜力.
科学领域:
- 生物医学研究的研究.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 长非编码RNAs (lncRNAs) 是人类疾病中涉及的基因表达的关键调节者.
- ARAP1-AS1,一种新型的lncRNA,越来越多地被认为是其在固体瘤中的致癌功能.
研究的目的:
- 审查ARAP1-AS1在恶性瘤中的调节作用.
- 讨论其作为生物标志物和治疗点的潜在临床应用.
- 识别知识缺口,并建议未来的研究方向.
主要方法:
- 对癌症中ARAP1-AS1功能研究的文献综述.
- 分析ARAP1-AS1的作用机制,包括miRNA海绵和蛋白质相互作用.
- 评估ARAP1-AS1对瘤发生和转移的影响.
主要成果:
- 在各种固体瘤中,ARAP1-AS1过度表达.
- 它通过基因表达调节促进瘤发生和转移.
- ARAP1-AS1与microRNAs和蛋白质相互作用以发挥其作用.
结论:
- ARAP1-AS1是一种显著的瘤性 lncRNA,在癌症进展中起着至关重要的作用.
- 它作为诊断生物标志物和固体瘤的治疗标具有前景.
- 需要进一步的研究,以充分阐明其机制和临床效用.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
RNA Splicing
56.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K


